These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1777726)
61. Sundowning syndrome and hypothalamic-pituitary-adrenal axis dysregulation in individuals with Alzheimer's disease: is there an association? Venturelli M; Scarsini R; Muti E; Salvagno GL; Schena F J Am Geriatr Soc; 2013 Nov; 61(11):2055-6. PubMed ID: 24219216 [No Abstract] [Full Text] [Related]
62. Hypothalamic-pituitary-adrenal axis stress test in patients with early RA: role of corticotropin-releasing hormone promoter polymorphisms. Malysheva O; Wagner U; Wahle M; Pierer M; Wagner U; Stalla GK; Baerwald CG Ann Rheum Dis; 2011 Nov; 70(11):2058-9. PubMed ID: 21666229 [No Abstract] [Full Text] [Related]
63. The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease. Swanwick GR; Coen RF; Walsh JB; Coakley D; Lawlor BA Biol Psychiatry; 1996 Jun; 39(11):976-8. PubMed ID: 9162211 [No Abstract] [Full Text] [Related]
64. [Brain imaging: neuropathologic applications to Alzheimer's disease: role of tomodensitometry and endocrine evaluation]. Leonardi M; Martelli A; Costa A; Mauri M; Zanotti B; Zappoli F Bull Assoc Anat (Nancy); 1991 Jun; 75(229):97-9. PubMed ID: 1777726 [No Abstract] [Full Text] [Related]
65. Endocrine changes in Alzheimer's disease. Davidson M; Bastiaens L; Davis BM; Shah MB; Davis KL Neurol Clin; 1988 Feb; 6(1):149-57. PubMed ID: 2898094 [TBL] [Abstract][Full Text] [Related]
66. [CRH receptor: evaluation of the receptor functions]. Horiba N; Suda T Nihon Rinsho; 1997 Apr; 55 Suppl 2():472-5. PubMed ID: 9172569 [No Abstract] [Full Text] [Related]
67. [Dynamics of the reactions of the hypothalamo-pituitary-adrenal system during stress]. Viru AA Usp Sovrem Biol; 1979; 87(2):271-86. PubMed ID: 222086 [No Abstract] [Full Text] [Related]
69. The neuroprotective actions of corticotropin releasing hormone. Bayatti N; Behl C Ageing Res Rev; 2005 May; 4(2):258-70. PubMed ID: 16046283 [TBL] [Abstract][Full Text] [Related]
70. The hypothalamic-pituitary-adrenal axis in anorexia nervosa and bulimia nervosa: pathophysiologic implications. Laue L; Gold PW; Richmond A; Chrousos GP Adv Pediatr; 1991; 38():287-316. PubMed ID: 1656715 [No Abstract] [Full Text] [Related]
71. The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis. Scott LV; Dinan TG Funct Neurol; 1999; 14(1):3-11. PubMed ID: 10321324 [No Abstract] [Full Text] [Related]
72. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Glynn LM; Davis EP; Sandman CA Neuropeptides; 2013 Dec; 47(6):363-70. PubMed ID: 24210135 [TBL] [Abstract][Full Text] [Related]
73. Cognitive function at menopause: neuroendocrine implications for the study of the aging brain. Costa A; Nappi RE; Sinforiani E; Bono G; Poma A; Nappi G Funct Neurol; 1997; 12(3-4):175-80. PubMed ID: 9218973 [No Abstract] [Full Text] [Related]
75. Chronic fatigue syndrome: the need for an integrative approach. Demitrack MA; Greden JF Biol Psychiatry; 1991 Oct; 30(8):747-52. PubMed ID: 1751618 [No Abstract] [Full Text] [Related]
76. The role of the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis. Eijsbouts AM; Murphy EP Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):599-613. PubMed ID: 10652642 [TBL] [Abstract][Full Text] [Related]
77. The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease. Goudsmit E; Neijmeijer-Leloux A; Swaab DF Prog Brain Res; 1992; 93():237-47; discussion 247-8. PubMed ID: 1480751 [TBL] [Abstract][Full Text] [Related]